← All diseases
Lungs and airways
Cystic fibrosis
Do you want to receive a message when there is new research about cystic fibrosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication there is one sentence that explains what was studied — and you receive notification as soon as there is new research on Cystic Fibrosis. View what Premium costs.
Publications (1953)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis. (2025/06/01) ♡
- Chalazion and Hordeolum Development in Patients with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor Therapy. (2025/06/01) ♡
- Respiratory viruses were frequently detected in young children with cystic fibrosis but had limited clinical significance. (2025/06/01) ♡
- Burkholderia Cenocepacia MALDI-ToF Mass Spectra in the Assessing the Course of Lower Respiratory Tract Infection in Patients with Cystic Fibrosis. (2025/06/01) ♡
- Technology and Human Support Systems in Decentralized Studies: A Participant-Centered Case Study in Cystic Fibrosis. (2025/05/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway. (2025/05/10) ♡
- Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. (2025/05/07) ♡
- [Adverse effects of the tezacaftor/ivacaftor/elexacaftor combination that may lead to discontinuation: About a series of 10 cases]. (2025/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of cystic fibrosis related liver disease in a pediatric cohort. (2025/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent developments in cystic fibrosis drug discovery: where are we today? (2025/05/01) ♡
- Pre-formulation development of highly potent nontuberculous mycobacterial agents. (2025/05/01) ♡
- The significant impact of meconium ileus on clinical outcomes among Brazilian individuals with cystic fibrosis-a retrospective analysis of a patient registry. (2025/04/28) ♡
- Regulation of Branchial Anoctamin 1 Expression in Freshwater- and Seawater-Acclimated Japanese Medaka, Oryzias latipes. (2025/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring. (2025/04/01) ♡
- "How Do You Live the Best Life You Can With This Pain?" A Qualitative Study of Adults Living With CF and Pain in the Modulator ERA. (2025/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Continuous Glucose Monitoring Systems and the Efficacy of Acarbose Treatment in Cystic Fibrosis-related Dysglycemia. (2025/03/19) ♡
- Cancers attributable to diet in Italy. (2025/03/15) ♡
- Efficacy of Adding Oral N acetyl Cysteine Supplement to the Cystic Fibrosis Treatment Regimen: A Randomized Quasi-Experimental Trial. (2025/03/11) ♡
- Vancomycin Population Pharmacokinetic Models in Non- Critically Ill Adults Patients: a scoping review. (2025/03/06) ♡
- How Do Early Weight Trajectories Explain Social Inequalities in Lung Function in Children With Cystic Fibrosis?: A Longitudinal Interventional Disparity Effects Analysis With Time-varying Mediators and Intermediate Confounders. (2025/03/01) ♡
- Disparities in outcomes by race and ethnicity in the Canadian cystic fibrosis population. (2025/03/01) ♡
- Associations between income level and health outcomes in people with cystic fibrosis in Turkey. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the restoration of CFTR in children and pwCF with "mild disease". (2025/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Proton-Pump Inhibitors and Fat Absorption in Cystic Fibrosis and Pancreatic Insufficiency: A Randomized Crossover Pilot Trial. (2025/03/01) ♡
- ACBP/DBI neutralization for the experimental treatment of fatty liver disease. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cholangiocyte organoids for disease, cancer, and regenerative medicine. (2025/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Possible Drug Interaction Between Elexacaftor-Tezacaftor-Ivacaftor and Repaglinide in an Adult With Cystic Fibrosis-related Diabetes. (2025/03/01) ♡
- A Three-year Longitudinal Assessment of Pseudomonas aeruginosa Antibiotic Susceptibility in Children With Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy. (2025/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence and outcomes of arthritis in pediatric IBD: A multicenter study from the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bronchiectasis and neutrophil dominant inflammation. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunomodulatory therapy by macrolides: More than killing bugs. (2025/03/01) ♡
- Adapting historical clinical genetic test records for anonymised data linkage: obstacles and opportunities. (2025/02/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Herbal Plants and their Phytoconstituents Based Remedies for Respiratory Diseases: A Review. (2025/02/12) ♡
- Collaboration between registered dietitians and gastroenterologists in cystic fibrosis care: Results of an international cross-sectional survey. (2025/02/01) ♡
- Recent trends in foreign body ingestion (FBI) epidemiology: A national cohort study. (2025/02/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations. (2025/02/01) ♡
- Heterogeneity in Pancreatitis: Recognizing Heterogeneity and Its Role in the Management of Pancreatitis Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. (2025/02/01) ♡
- Drug Treatment of Cystic Fibrosis and Breastfeeding. (2025/02/01) ♡
- Disorder within order: Identification of the disordered loop of STAS domain as the inhibitory domain in SLC26A9 chloride channel. (2025/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intravitreal topotecan injection-induced conjunctival fibrosis mimicking extraocular extension of retinoblastoma: a rare complication. (2025/02/01) ♡
- Prevalence and characteristics of gastrointestinal disorders, medication use, and diagnostic interventions in pediatric patients with cystic fibrosis: a nested case-control analysis from the TriNetX EMR-derived global research network real-world dataset. (2025/01/24) ♡
- Development of a registry to evaluate immobilized lipase cartridge use in pediatric patients with short bowel syndrome/intestinal failure. (2025/01/16) ♡
- Restoring natural killer cell activity in lung injury with 1,25-hydroxy vitamin D(3): a promising therapeutic approach. (2025/01/07) ♡
- Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity. (2025/01/06) ♡
- Application of low-dose FDG-PET/MRI for quantification of lung changes in pediatric patients with cystic fibrosis: a new inflammatory index. (2025/01/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2. (2025/01/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Clinical Efficacy and Safety of Treatments for Exocrine Pancreatic Insufficiency: A Systematic Literature Review. (2025/01/01) ♡
- Linkage of the CF Foundation Patient Registry with the Scientific Registry of Transplant Recipients database. (2025/01/01) ♡
- Diabetes remission in adults with cystic fibrosis commenced on Elexacaftor/Tezacaftor/Ivacaftor: A single center case-series. (2025/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.